| NCT Number | NCT04838171 |
| Lead Sponsor | Quell Therapeutics Limited |
| Conditions | Autoimmune Diseases, Inflammation, Rejection; Transplant, Liver |
| Enrollment | 10 participants |
| Start Date | 2021-03-24 |
| Primary Completion | 2029-12-31 (estimated) |
| Study Completion | 2030-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-21 |